Clinical Trial: GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF Registry

U.S., Aug. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07787936) titled 'GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF Registry' on Aug. 18.

Brief Summary: GLIDE-HF is a prospective, single-center, non-interventional observational cohort registry conducted within routine outpatient heart failure care at a cardiology clinic in Poland. It enrolls patients with obesity-related heart failure with preserved ejection fraction (HFpEF), defined by chronic heart failure symptoms or exertional dyspnea, body mass index at least 30 kg/m2, left ventricular ejection fraction at least 50%, and objective evidence of HFpEF using contemporary diagnostic scores (H2FPEF and HFA-PEFF), without a dominant...